Track the Nureca stock price and the full management transaction log of the company, a listed equity based in India. Shares are listed on the IN market, under the supervision of SEBI (PIT + SAST). Market capitalisation: €3.1bn. The latest transaction was reported on 29 August 2026 (Acquisition). Among the most active insiders: Smita Goyal. The full history is accessible without an account.
19
Insider Decl.
n/a
Thresholds
€287,997
15 ops.
Buy Volume
n/a
4 ops.
Sell Volume
30Σ signal
Buys €287,997n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,768 of 29,062 companies
37.3
score / 100
Value
25
Quality
50
FCF yld-1.1%
Earn yld0.7%
EV/EBITDA42.9x
ROE1.1%
Gross mgn36%
Net mgn1.4%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
60,842 shares@ ₹236.20100.0% of flowEquity SharesOff MarketSEBI:80ef25067d1dd83aa846af3109c72355fc35fe4f
Canonical exit: 7 Sept 2026 (T+90)
19 of 19 declarations
Acerca de Nureca
Nureca es una empresa que cotiza en la XBOM, especializada en el suministro de productos de salud y bienestar. Se centra en la innovación y la calidad para mejorar la vida de los consumidores.